KTP激光联合典必殊眼膏治疗泪小(总)管阻塞的远期疗效观察

目的:评价KTP激光泪道疏通术联合典必殊眼膏填充治疗泪小(总)管阻塞的远期疗效。方法:分别对42例44眼泪小管阻塞和38例39眼泪总管阻塞患者施行KTP激光泪道疏通术联合典必殊眼膏填充,并在术后定期用庆大霉素、地塞米松和糜蛋白酶扩张冲洗泪道,随访24～30mo,观察患者的疗效。结果:44眼泪小管阻塞治愈40眼,有效4眼,治愈率91%;39眼泪总管阻塞治愈34眼,有效5眼,治愈率87%。结论:KTP激光泪道疏通术联合典必殊眼膏填充治疗泪小(总)管阻塞对组织损伤小、治愈率高,远期疗效肯定。

Observation on the long-term effect in treating canaliculus or lacrimal common duct obstruction by KTP laser with TobraDex eye ointment

AIM:To evaluate the long-term therapeutic effect of canaliculus or lacrimal common duct obstruction by KTP laser endolacrimal recanalisationm with TobraDex eye ointment infusion.·METHODS: KTP laser endolacrimal recanalisationm with TobraDex eye ointment infusion was applied in 42 cases(44 eyes) with canaliculus obstruction and 38 cases(39 eyes) with lacrimal common duct obstruction,lacrimal duct of which were regularly irrigated and dilated postoperatively. The follow-up lasted for 24 to 30 months to observe the therapeutic effect. ·RESULTS: Forty eyes were cured in 44 eyes with canaliculus obstruction;and 34 eyes were cured in 39 eyes with lacrimal common duct obstruction;the curative rate was 91%,87% respectively. ·CONCLUSION: KTP laser endolacrimal recanalisationm with TobraDex eye ointment infusion has a high successful rate,minimal tissue damage,and the long-term effect is satisfied.